dacarbazine has been researched along with guanosine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chamberlain, MC | 1 |
| Blair, AA; Ellenbogen, RG; Gebhart, RN; Jeon, M; Silber, JR; Stephen, ZR; Zhang, M | 1 |
| Dal-Cim, TA; Lopes, FG; Nedel, CB; Oliveira, KA; Tasca, CI | 1 |
3 other study(ies) available for dacarbazine and guanosine
| Article | Year |
|---|---|
Treatment of newly diagnosed malignant glioma in the elderly people: new trials that impact therapy.
Topics: Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Chemoradiotherapy; Dacarbazine; Glioblastoma; Guanosine; Humans; Methylation; Middle Aged; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Survival Rate; Temozolomide | 2013 |
pH-Sensitive O6-Benzylguanosine Polymer Modified Magnetic Nanoparticles for Treatment of Glioblastomas.
Topics: Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Glioblastoma; Guanosine; Humans; Hydrogen-Ion Concentration; Microscopy, Electron, Transmission; O(6)-Methylguanine-DNA Methyltransferase; Polymers; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Temozolomide | 2017 |
Guanosine promotes cytotoxicity via adenosine receptors and induces apoptosis in temozolomide-treated A172 glioma cells.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Autophagy; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Dacarbazine; Glioma; Guanosine; Humans; Membrane Potential, Mitochondrial; Receptors, Purinergic P1; Temozolomide | 2017 |